Search results
Results from the WOW.Com Content Network
The attachment of these capping/stabilizing agents slows and eventually stops the growth of the particle. [5] The most common capping ligands are trisodium citrate and polyvinylpyrrolidone (PVP), but many others are also used in varying conditions to synthesize particles with particular sizes, shapes, and surface properties.
Insulin glargine, for example, is designed to precipitate after injection so it can be slowly absorbed by the body over a longer period than regular insulin would be. [13] Depot injections of insulins have been studied to better replicate the body's natural basal rate of insulin production, and which can be activated by light to control the ...
"ATC: Introduction - page 2 of CAPS" (PDF). Family Medicine Research Centre. Archived (PDF) from the original on 2022-10-09. from "Health classifications and terminologies - CAPS - Coding Atlas for Pharmaceutical Substances". Faculty of Medicine and Health University of Sydney; EphMRA Anatomical Classification (ATC and NFC) atcd.
In many cells these pits and complexes begin to concentrate in one area of a cell. Cytochemically, this appears as patches of label on the cell surface (patching). Eventually, the patches coalesce to form a cap at one pole of the cell (capping). Not all cells form caps, but most do form patches.
An excipient is a substance formulated alongside the active ingredient of a medication.They may be used to enhance the active ingredient’s therapeutic properties; to facilitate drug absorption; to reduce viscosity; to enhance solubility; to improve long-term stabilization (preventing denaturation and aggregation during the expected shelf life); or to add bulk to solid formulations that have ...
Get AOL Mail for FREE! Manage your email like never before with travel, photo & document views. Personalize your inbox with themes & tabs. You've Got Mail!
A capping agent is used during nanoparticle synthesis to inhibit particle growth and aggregation. The chemical blocks or reduces reactivity at the periphery of the particle—a good capping agent has a high affinity for the new nuclei. [112] Citrate ions or tannic acid function both as a reducing agent and a capping agent.
An enteric coating is a polymer barrier applied to oral medication that prevents its dissolution or disintegration in the gastric environment. [1] This helps by either protecting drugs from the acidity of the stomach, the stomach from the detrimental effects of the drug, or to release the drug after the stomach (usually in the upper tract of the intestine). [2]